Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)
Clinical trial NCT01392183 · COMPLETED
Trial details
- NCT number
- NCT01392183
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-24
- Primary completion
- 2019-09-08
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.